Given the recent identification of ADAM10 as the sheddases for RAGE, it is conceivable that the decrease in plasma sRAGE may be due to the decrease in either ADAM10 expression or ADAM10 activity in AD patients. This evidence concerns the gene AGER and Alzheimer disease.